476 related articles for article (PubMed ID: 25948589)
1. Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis.
Ruscetti M; Quach B; Dadashian EL; Mulholland DJ; Wu H
Cancer Res; 2015 Jul; 75(13):2749-59. PubMed ID: 25948589
[TBL] [Abstract][Full Text] [Related]
2. A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristics.
Harner-Foreman N; Vadakekolathu J; Laversin SA; Mathieu MG; Reeder S; Pockley AG; Rees RC; Boocock DJ
Sci Rep; 2017 Jan; 7():40633. PubMed ID: 28094783
[TBL] [Abstract][Full Text] [Related]
3. HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer.
Ruscetti M; Dadashian EL; Guo W; Quach B; Mulholland DJ; Park JW; Tran LM; Kobayashi N; Bianchi-Frias D; Xing Y; Nelson PS; Wu H
Oncogene; 2016 Jul; 35(29):3781-95. PubMed ID: 26640144
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?
Nauseef JT; Henry MD
Nat Rev Urol; 2011 Jun; 8(8):428-39. PubMed ID: 21691304
[TBL] [Abstract][Full Text] [Related]
5. Fusion with mesenchymal stem cells differentially affects tumorigenic and metastatic abilities of lung cancer cells.
Zhang LN; Kong CF; Zhao D; Cong XL; Wang SS; Ma L; Huang YH
J Cell Physiol; 2019 Apr; 234(4):3570-3582. PubMed ID: 30417342
[TBL] [Abstract][Full Text] [Related]
6. Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells.
Kong D; Banerjee S; Ahmad A; Li Y; Wang Z; Sethi S; Sarkar FH
PLoS One; 2010 Aug; 5(8):e12445. PubMed ID: 20805998
[TBL] [Abstract][Full Text] [Related]
7. Cells susceptible to epithelial-mesenchymal transition are enriched in stem-like side population cells from prostate cancer.
Luo Y; Cui X; Zhao J; Han Y; Li M; Lin Y; Jiang Y; Lan L
Oncol Rep; 2014 Feb; 31(2):874-84. PubMed ID: 24316717
[TBL] [Abstract][Full Text] [Related]
8. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
Liao TT; Yang MH
Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer-associated mesenchymal stem cells promote tumor metastasis and tumorigenesis by induction of epithelial-mesenchymal transition and stem-like reprogram.
Yan C; Chang J; Song X; Qi Y; Ji Z; Liu T; Yu W; Wei F; Yang L; Ren X
Aging (Albany NY); 2021 Mar; 13(7):9780-9800. PubMed ID: 33744858
[TBL] [Abstract][Full Text] [Related]
10. The metastasis suppressor CD82/KAI1 represses the TGF-β
Lee MS; Lee J; Kim YM; Lee H
Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
[TBL] [Abstract][Full Text] [Related]
11. Collapsin response mediator protein-1 (CRMP1) acts as an invasion and metastasis suppressor of prostate cancer via its suppression of epithelial-mesenchymal transition and remodeling of actin cytoskeleton organization.
Cai G; Wu D; Wang Z; Xu Z; Wong KB; Ng CF; Chan FL; Yu S
Oncogene; 2017 Jan; 36(4):546-558. PubMed ID: 27321179
[TBL] [Abstract][Full Text] [Related]
12. Progressive epithelial to mesenchymal transitions in ARCaP E prostate cancer cells during xenograft tumor formation and metastasis.
He H; Yang X; Davidson AJ; Wu D; Marshall FF; Chung LW; Zhau HE; Wang R
Prostate; 2010 Apr; 70(5):518-28. PubMed ID: 19918799
[TBL] [Abstract][Full Text] [Related]
13. Hydrodynamic shear stress promotes epithelial-mesenchymal transition by downregulating ERK and GSK3β activities.
Choi HY; Yang GM; Dayem AA; Saha SK; Kim K; Yoo Y; Hong K; Kim JH; Yee C; Lee KM; Cho SG
Breast Cancer Res; 2019 Jan; 21(1):6. PubMed ID: 30651129
[TBL] [Abstract][Full Text] [Related]
14. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
[TBL] [Abstract][Full Text] [Related]
15. Contributions of epithelial-mesenchymal transition and cancer stem cells to the development of castration resistance of prostate cancer.
Li P; Yang R; Gao WQ
Mol Cancer; 2014 Mar; 13():55. PubMed ID: 24618337
[TBL] [Abstract][Full Text] [Related]
16. Chronic CagA-positive Helicobacter pylori infection with MNNG stimulation synergistically induces mesenchymal and cancer stem cell-like properties in gastric mucosal epithelial cells.
Lin L; Wei H; Yi J; Xie B; Chen J; Zhou C; Wang L; Yang Y
J Cell Biochem; 2019 Oct; 120(10):17635-17649. PubMed ID: 31209915
[TBL] [Abstract][Full Text] [Related]
17. EMT and acquisition of stem cell-like properties are involved in spontaneous formation of tumorigenic hybrids between lung cancer and bone marrow-derived mesenchymal stem cells.
Xu MH; Gao X; Luo D; Zhou XD; Xiong W; Liu GX
PLoS One; 2014; 9(2):e87893. PubMed ID: 24516569
[TBL] [Abstract][Full Text] [Related]
18. Disseminating cells in human oral tumours possess an EMT cancer stem cell marker profile that is predictive of metastasis in image-based machine learning.
Youssef G; Gammon L; Ambler L; Lunetto S; Scemama A; Cottom H; Piper K; Mackenzie IC; Philpott MP; Biddle A
Elife; 2023 Nov; 12():. PubMed ID: 37975646
[TBL] [Abstract][Full Text] [Related]
19. Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells.
Mulholland DJ; Kobayashi N; Ruscetti M; Zhi A; Tran LM; Huang J; Gleave M; Wu H
Cancer Res; 2012 Apr; 72(7):1878-89. PubMed ID: 22350410
[TBL] [Abstract][Full Text] [Related]
20. Zebrafish Microenvironment Elevates EMT and CSC-Like Phenotype of Engrafted Prostate Cancer Cells.
Chen L; Boleslaw Olszewski M; Kruithof-de Julio M; Snaar-Jagalska BE
Cells; 2020 Mar; 9(4):. PubMed ID: 32225005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
